RHO Phyto™
RHO Phyto™
Pharmaceutical-Grade Cannabinoid Formulations
The formulary of proprietary medical cannabis products marketed are under the RHO Phyto™ brand and offer a range of standardized cannabinoid formulations across multiple delivery systems with multi-cannabinoid formulation matrices including CBD, THC, CBN, and CBG. RHO Phyto™ products use proprietary drug delivery systems designed to enhance bioavailability and dosing precision, and are supported by pre-clinical, clinical, and real-world evidence.
University Health
Network
Medical Cannabis by Shoppers Commercial Portal
Including oral, sublingual, topical, and transdermal deliveries that have controlled dosing, enhanced absorption and stability studies supported by pre-clinical data
Canada’s leading pharmacy retailer with more than 30,000+ registered cannabis patients
Collaborative education and training strategy with clinics in the medical community
Successful segmentation medical patients and aging population
51%
women
75%
sales are to 41+ years of age
Clinical Channels
Sunnybrook Hospital: first medical cannabis brand to be available for dispensing in major hospital pharmacy
UHN-RWET: University Health Network medical cannabis real world evidence study
Commercial Channels
Commercial across Canada, Colombia and Barbados
Commercial across 3 channels in Canada including Adult Use, Clinical and Medical in partnership with Medical Cannabis by Shoppers
Adult use channel. Establishing the wellness category in partnership with retailers across – ON, AB, NB, SK and NB
Visit Us
